The worldwide Alopecia Market stood at USD 8.6 billion in 2023, and is anticipated to reach USD 17.8 billion by 2031, recording a CAGR of 9.8% from 2024 through 2031.
Alopecia covers an autoimmune disease that damages hair follicles and causes hair loss. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is underpinned by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Alopecia Market Snapshot
Chapter 4. Global Alopecia Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Alopecia Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Alopecia Industry Trends
Chapter 5. Alopecia Market Segmentation 1: By Disease Type, Estimates & Trend Analysis
5.1. Market Share by Disease Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Type
5.2.1. Alopecia Areata
5.2.2. Cicatricial Alopecia
5.2.3. Traction Alopecia
5.2.4. Alopecia Totalis
5.2.5. Alopecia Universalis
5.2.6. Androgenetic Alopecia
5.2.7. Others
Chapter 6. Alopecia Market Segmentation 2: By Treatment, Estimates & Trend Analysis
6.1. Market Share by Treatment, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Treatments:
6.2.1. Pharmaceuticals
6.2.1.1. Topical
6.2.1.1.1. OTC
6.2.1.1.1.1. Minoxidil
6.2.1.1.1.2. Others
6.2.1.1.2. Prescription
6.2.1.1.2.1. Betamethasone Dipropionate
6.2.1.1.2.2. Fluocinolone Acetonide
6.2.1.1.2.3. Finasteride
6.2.1.1.2.4. Minoxidil
6.2.1.2. Oral
6.2.1.2.1. OTC
6.2.1.2.1.1 Prescription
6.2.1.2.1.1. Minoxidil
6.2.1.2.1.2. Finasteride
6.2.1.2.1.3. Corticosteroids
6.2.1.2.1.4. Others (JAK inhibitors and others)
6.2.1.2.2. PRP
6.2.2. Devices
6.2.2.1. Laser Cap
6.2.2.2. Laser Comb
6.2.2.3. Laser Helmet
Chapter 7. Alopecia Market Segmentation 3: By Gender, Estimates & Trend Analysis
7.1. Market Share by Gender, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Gender:
7.2.1. Male
7.2.2. Female
Chapter 8. Alopecia Market Segmentation 4: By Sales Channel, Estimates & Trend Analysis
8.1. Market Share by Sales Channel, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Sales Channel:
8.2.1. Prescriptions
8.2.2. OTC
Chapter 9. Alopecia Market Segmentation 5: By End User, Estimates & Trend Analysis
9.1. Market Share by End User, 2023 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End User:
9.2.1. Homecare Settings
9.2.2. Dermatology Clinics
Chapter 10. Alopecia Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Alopecia Market, Regional Snapshot 2023 & 2031
10.2. North America
10.2.1. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.2.3. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.2.4. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.2.5. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.2.6. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.3. Europe
10.3.1. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.3.3. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.3.4. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.3.5. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.3.6. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.4. Asia Pacific
10.4.1. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.4.3. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.4.4. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.4.5. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts By Sales Channel, 2024-2031
10.4.6. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.5. Latin America
10.5.1. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.5.3. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.5.4. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.5.5. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.5.6. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.6. Middle East & Africa
10.6.1. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.6.3. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.6.4. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.6.5. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.6.6. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Janssen Global Services Inc.
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service Offerings
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Cipla Limited
11.2.3. Merck & Co., Inc.
11.2.4. GlaxoSmithKline Plc
11.2.5. Sun Pharmaceuticals Industries Ltd
11.2.6. Dr Reddy's Laboratories Ltd
11.2.7. Aurobindo Pharma
11.2.8. Viatris Inc.
11.2.9. Pfizer, Inc.
11.2.10. Eli Lilly
11.2.11. Lexington Intl., LLC
11.2.12. Freedom Laser Therapy
11.2.13. Curallux, LLC
11.2.14. Apira Sciences Inc.
11.2.15. Revian Inc.
11.2.16. Theradome
11.2.17. Lutronic
11.2.18. iRestore Hair Growth System
11.2.19. iGrow Laser
11.2.20. Theradome
11.2.21. Other Prominent Players